Report #2866109

Received Oct 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: TN
Recovered: Unknown
Vaccinated: Sep 21, 2025
Onset: Sep 21, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
UNK	VACCINE NOT SPECIFIED (NO BRAND NAME)	UNKNOWN MANUFACTURER	UNK	9CC9K	SYR

Symptoms (1)

Incorrect route of product administration

Symptom narrative

patient had received a dose of Fluarix via IV; This non-serious case was reported by a other health professional via call center representative and described the occurrence of intramuscular formulation administered by other route in a female patient who received Flu Seasonal TIV Dresden (Fluarix 2025-2026 season) (batch number 9CC9K, expiry date 30-JUN-2026) for prophylaxis. On 21-SEP-2025, the patient received Fluarix 2025-2026 season (intravenous). On 21-SEP-2025, an unknown time after receiving Fluarix 2025-2026 season, the patient experienced intramuscular formulation administered by other route (Verbatim: patient had received a dose of Fluarix via IV). The outcome of the intramuscular formulation administered by other route was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-SEP-2025 No further details were provided.